Market Research Logo

Europe Cancer Biomarker Market Forecast 2017-2025

Europe Cancer Biomarker Market Forecast 2017-2025KEY FINDINGS

The Europe cancer biomarker market is poised to grow at a CAGR of 13.46% for the years 2017-2025. The total income generated by the market is also predicted to increase to up to $8646 million by the end of this forecast period.

MARKET INSIGHTS

The European market has a huge opportunity to grow in personalized medication on account of the support generated for the biomarkers test, growing medical tourism, and the rising number of cancer patients in the region. Also, the various market segments and sub-segments with respect to diseases, discovery, and diagnosis are proving to be quite profitable for the market growth. However, the lack of acceptance of the cancer biomarker from the general populace, unfavorable compensation situation and a shortage of skilled personnel remains to be the major issues faced by the market.

COMPETIIVE INSIGHTS

Clarient Inc, Becton Dickinson and Company, Ambrilia Biopharma Inc, Abbott Laboratories, Roche Diagnostics Ltd, Qiagen N.V, Affymetrix Inc, etc are some of the leading players in the market.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Key Findings
4. Market Determinants
4.1. Market Drivers
4.1.1. Adoption Of Western Lifestyles In Developing Regions
4.1.2. Growing Prevalence On Research Of Cancer Biomarkers
4.1.3. Encouragement For Biomarker Development By Fda
4.1.4. Improved Precision And Speed Of Diagnosis
4.1.5. High Investment Through Government And Private Funds In Cancer Related Research
4.1.6. Development Of Highly Specific Drugs
4.2. Restraints
4.2.1. Poor Compensation Structures
4.2.2. Low Estimated Rate Of Successful Clinical Trials Of Biomarkers
4.2.3. Technical Issues Related To Cancer Biomarkers
4.3. Market Opportunities
4.3.1. Wide Opportunity To Grow In Personalized Medication
4.3.2. Supports On Biomarkers Test
4.3.3. Growing Number Of Cancer Patients And Growing Medical Tourism In Emerging Economies
4.4. Market Challenges
4.4.1. Lacking Acceptance Of The Cancer Biomarker
4.4.2. Unfavorable Compensation Situation
4.4.3. High Cost Of Developing Companion Diagnostics
4.4.4. Rigorous Regulatory Agenda
4.4.5. Dearth Of Skilful Workers
5. Market Segmentation
5.1. Market By Discovery And Diagnostics 2017-2025
5.1.1. Biomarker Discovery
5.1.1.1. Genetic Methods
5.1.1.1.1. Dna Arrays
5.1.1.1.2. Polymerase Chain Reaction (Pcr)
5.1.1.1.3. Reverse Transcriptase Polymerase Chain Reaction (Rt-pcr)
5.1.1.1.4. Fluorescent In Situ Hybridization (Fish)
5.1.1.1.5. Southern Blot
5.1.1.2. Imaging
5.1.1.2.1. Magnetic Resonance Imaging (Mri)
5.1.1.2.2. Computed Tomography (Ct)
5.1.1.2.3. Positron Emission Tomography (Pet)
5.1.1.2.4. Ultrasound
5.1.1.2.5. Single-photon Emission Computed Tomography (Spect)
5.1.1.2.6. X-ray
5.1.1.2.7. Magnetic Resonance Spectroscopy (Mrs)
5.1.1.2.8. Biophotonics
5.1.1.3. Protein Methods
5.1.1.3.1. Mass Spectrometry (Ms)
5.1.1.3.2. Immunohistochemistry (Ihc)
5.1.1.4. Metabolomics
5.1.2. Biomarker Diagnostic
5.1.2.1. Genetic And Genomic Markers
5.1.2.2. Proteomics
5.1.2.3. Dna Microarrays
5.1.2.4. Immunoassays
5.1.2.5. Immunohistochemical Tests
5.1.2.6. Pharmacogenomics
5.1.2.7. Molecular (Dna And Genomic) Diagnostic Assays
5.1.2.8. Flow Cytometry
5.1.2.9. Monoclonal Antibodies
5.1.2.10. Stem Cell Markers
5.1.2.11. Invitro Diagnostic Multivariate Index
5.2. Market By Disease 2017-2025
5.2.1. Lung Cancer
5.2.2. Breast Cancer
5.2.3. Colorectal Cancer
5.2.4. Prostate Cancer
5.2.5. Cervical Cancer
5.2.6. Other Cancer
6. Key Analytics
6.1. Porters Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Product
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Suppliers
6.1.5. Intensity Of Competitive Rivalry
6.2. Opportunity Matrix
6.3. Key Buying Criteria
6.3.1. Pricing
6.3.2. Efficacy
6.3.3. Application And Effectiveness
6.4. Vendor Landscape
7. Geographic Analysis
7.1. Europe
7.1.1. United Kingdom (Uk)
7.1.2. France
7.1.3. Germany
7.1.4. Spain
7.1.5. Italy
7.1.6. Rest Of Europe
8. Company Profiling
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.1.2. Top Winning Strategies
8.2. Abbott Laboratories
8.2.1. Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Affymetrix, Inc.(Acquired By Thermofisher)
8.3.1. Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Agendia N.V.
8.4.1. Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Agilent Technologies, Inc.
8.5.1. Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Astellas Pharma Inc.
8.6.1. Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Becton Dickinson And Company
8.7.1. Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Clarient, Inc. (Acquired By Neogenomics Laboratories)
8.8.1. Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Diadexus Inc. (Acquired By Diazyme Laboratories)
8.9.1. Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Illumina, Inc
8.10.1. Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Qiagen N.V. Overview
8.11.1. Product Portfolio
8.11.2. Scot Analysis
8.11.3. Strategic Initiatives
8.12. Roche Diagnostics Ltd
8.12.1. Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Ambrilia Biopharma Inc.
8.13.1. Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Aureon Biosciences, Inc
8.14.1. Beckman Coulter Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Biomoda Inc.
8.15.1. Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
Table List
Table # 1 Recent Research On Biomarkers
Table # 2 List Of Fda Approved Protein Cancer Biomarkers (2015)
Table # 3 Potential Clinical Uses Of Cancer Biomarkers
Table # 4 Medical Tourism Prices In Us Dollar
Table # 5 Europe Cancer Biomarker Market, By Discovery And Diagnostics 2017-2025 ($million)
Table # 6 Europe Genetic Methods Market 2017-2025 ($million)
Table # 7 Europe Dna Arrays Market, 2017-2025 ($million)
Table # 8 Europe Polymerase Chain Reaction Market, 2017-2025 ($million)
Table # 9 Europe Reverse Transcriptase Polymerase Chain Reaction Market, 2017-2025 ($million)
Table # 10 Europe Fluorescent In Situ Hybridization Market, 2017-2025 ($million)
Table # 11 Europe Southern Blot Market, 2017-2025 ($million)
Table # 12 Europe Imaging Market 2017-2025 ($million)
Table # 13 Europe Imaging Market, 2017-2025 ($million)
Table # 14 Europe Magnetic Resonance Imaging Market, 2017-2025 ($million)
Table # 15 Europe Computed Tomography Market, 2017-2025 ($million)
Table # 16 Europe Positron Emission Tomography Market, 2017-2025 ($million)
Table # 17 Europe Ultrasound Market, 2017-2025 ($million)
Table # 18 Europe Single Photon Emission Computed Tomography Market, 2017-2025 ($million)
Table # 19 Europe X-ray Market, 2017-2025 ($million)
Table # 20 Europe Magnetic Resonance Spectroscopy Market, 2017-2025 ($million)
Table # 21 Europe Biophotonics Market, 2017-2025 ($million)
Table # 22 Europe Protein Methods Market 2017-2025 ($million)
Table # 23 Europe Protein Methods Market, 2017-2025 ($million)
Table # 24 Europe Mass Spectrometry Market, 2017-2025 ($million)
Table # 25 Europe Immunohistochemistry Market, 2017-2025 ($million)
Table # 26 Europe Metabolomics Market, 2017-2025 ($million)
Table # 27 Europe Biomarker Diagnostic Market, 2017-2025 ($million)
Table # 28 Europe Genomics And Genetic Markers Market, 2017-2025 ($million)
Table # 29 Europe Proteomics Market, 2017-2025 ($million)
Table # 30 Europe Dna Microarrays Market, 2017-2025 ($million)
Table # 31 Europe Immunoassays Market, 2017-2025 ($million)
Table # 32 Europe Immunohistochemical Tests Market, 2017-2025 ($million)
Table # 33 Europe Pharmacogenomics Market, 2017-2025 ($million)
Table # 34 Europe Molecular (Dna And Genomic) Diagnostic Assays Market, 2017-2025 ($million)
Table # 35 Europe Flow Cytometry Market, 2017-2025 ($million)
Table # 36 Europe Monoclonal Antibodies Market, 2017-2025 ($million)
Table # 37 Europe Stem Cell Markers Market, 2017-2025 ($million)
Table # 38 Europe In Vitro Diagnostic Multivariate Index Assays Market, 2017-2025 ($million)
Table # 39 Europe Cancer Biomarkers Market, By Disease 2017-2025 ($million)
Table # 40 Europe Lung Cancer Market, 2017-2025 ($million)
Table # 41 Europe Breastcancer Market, 2017-2025 ($million)
Table # 42 Europe Colorectal Cancer Market, 2017-2025 ($million)
Table # 43 Europe Prostate Cancer Market, 2017-2025 ($million)
Table # 44 Human Specimens For Cancer Biomarker Discovery
Table # 45 Europe Cervical Cancer Market, 2017-2025 ($million)
Table # 46 List Of Fda-qualified Biomarkers
Table # 47 Europe Other Cancer Market, 2017-2025 ($million)
Table # 48 Estimated New Cancer Cases And Deaths For 2017, By Sex
Figures List
Figure # 1 Increasing Number Of People Living With Cancer Across The Globe For Period 2012-2020 (Million)
Figure # 2 Most Common Cancer Causing Deaths In 2015
Figure # 3 Pharmacogenomic Biomarkers Information In Drug Labeling
Figure # 4 Percentages Of Patients Ineffective For Particular Drug
Figure # 5 List Of Cleared Or Approved Companion Diagnostic Devices (Imaging Tools And In Vitro) By Fda
Figure # 6 Europe Genetic Methods Market 2017-2025 ($million)
Figure # 7 Europe Dna Arrays Market 2017-2025 ($million)
Figure # 8 Europe Polymerase Chain Reaction Market 2017-2025 ($million)
Figure # 9 Europe Reverse Transcriptase Polymerase Chain Reaction Market 2017-2025 ($million)
Figure # 10 Europe Fluorescent In Situ Hybridization Market 2017-2025 ($million)
Figure # 11 Europe Southern Blot Market 2017-2025 ($million)
Figure # 12 Europe Imaging Market 2017-2025 ($million)
Figure # 13 Europe Magnetic Resonance Imaging Market 2017-2025 ($million)
Figure # 14 Europe Computed Tomography Market 2017-2025 ($million)
Figure # 15 Europe Positron Emission Tomography Market 2017-2025 ($million)
Figure # 16 Europe Ultrasound Market 2017-2025 ($million)
Figure # 17 Europe Single Photon Emission Computed Tomography Market 2017-2025 ($million)
Figure # 18 Europe X-ray Market 2017-2025 ($million)
Figure # 19 Europe Magnetic Resonance Spectroscopy Market 2017-2025 ($million)
Figure # 20 Europe Biophotonics Market 2017-2025 ($million)
Figure # 21 Europe Protein Methods Market 2017-2025 ($million)
Figure # 22 Europe Mass Spectrometry Market 2017-2025 ($million)
Figure # 23 Europe Immunohistochemistry Market 2017-2025 ($million)
Figure # 24 Europe Metabolomics Market 2017-2025 ($million)
Figure # 25 Europe Genomics And Genetic Markers Market 2017-2025 ($million)
Figure # 26 Europe Proteomics Market 2017-2025 ($million)
Figure # 27 Europe Dna Microarrays Market 2017-2025 ($million)
Figure # 28 Europe Immunoassays Market 2017-2025 ($million)
Figure # 29 Europe Immunohistochemical Tests Market 2017-2025 ($million)
Figure # 30 Europe Pharmacogenomics Market 2017-2025 ($million)
Figure # 31 Europe Molecular (Dna And Genomic) Diagnostic Assays Market 2017-2025 ($million)
Figure # 32 Europe Flow Cytometry Market 2017-2025 ($million)
Figure # 33 Europe Monoclonal Antibodies Market 2017-2025 ($million)
Figure # 34 Europe Stem Cell Markers Market 2017-2025 ($million)
Figure # 35 Europe In Vitro Diagnostic Multivariate Index Assays Market 2017-2025 ($million)
Figure # 36 Europe Lung Cancer Market, 2017-2025 ($million)
Figure # 37 New Cases Of Lung & Bronchus Cancer And Associated Deaths, 2015
Figure # 38 Europe Breastcancer Market 2017-2025 ($million)
Figure # 39 Europe Colorectal Cancer Market 2017-2025 ($million)
Figure # 40 Statistics Of Colorectal Cancer In 2016
Figure # 41 Europe Prostate Cancer Market 2017-2025 ($million)
Figure # 42 Europe Cervical Cancer Market 2017-2025 ($million)
Figure # 43 Europe Other Cancer Market 2017-2025 ($million)
Figure # 44 Percentage Vise Distribution Of Various Cancers England (2015)
Figure # 45 Uk Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 46 Healtcare Spending Per Capita $
Figure # 47 France Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 48 Germany Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 49 Spain Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 50 Italy Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 51 Rest Of Europe Biomarkers Market 2017-2025 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report